Oberland Capital Closes $800 Million Healthcare Royalty and Credit Opportunities Fund at Hard Cap NEW YORK, September 6, 2018-- Oberland Capital, a healthcare focused investment firm, announced today the successful closing of its second royalty and credit opportunities fund, Oberland Capital Healthcare II LP ("Fund II"), at its hard cap of $800 million in capital commitments. Fund II will target investments between $20 million and $150 million with a focus on commercial stage or near-commercial stage biopharmaceutical, medical device and diagnostic companies and royalty-bearing products.